Core Viewpoint - Aurora Cannabis Inc. is set to discuss its strategic direction, recent milestones, and growth opportunities at the Canaccord Genuity 45th Annual Growth Conference, emphasizing its commitment to innovation and leadership in the global medical cannabis sector [2][6]. Group 1: Company Overview - Aurora Cannabis Inc. is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4]. - The company offers a diverse portfolio of brands, including adult-use brands such as Drift and San Rafael '71, and medical cannabis brands like MedReleaf and CanniMed [4]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4]. Group 2: Conference Details - The conference call is scheduled for August 13th at 1:30 PM Eastern Standard Time, with a live audio webcast available for registration [3]. - Simona King, the Chief Financial Officer, will participate in a fireside chat and conduct one-on-one meetings with investors throughout the day [1][3]. Group 3: Strategic Focus - The discussion at the conference will highlight Aurora's strategic direction and its commitment to innovation within the medical cannabis industry [2]. - The company aims to leverage recent milestones to identify and pursue growth opportunities in the evolving cannabis market [2].

Core Insights - Aurora Cannabis Inc. has been recognized in the Globe & Mail's 2025 Report on Business as an honouree in the Women Lead Here list, highlighting its commitment to gender diversity at the executive level [1][3] - The company boasts that 43% of its executive leadership team consists of women, emphasizing their role in driving change within the medical cannabis industry [2][3] - Aurora established the Women Empowerment Network (WEN) in 2022 to support the advancement of women within the organization, offering learning and community engagement opportunities [2] Company Overview - Aurora Cannabis Inc. is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company's product portfolio includes various adult-use brands such as Drift, San Rafael '71, and medical cannabis brands like MedReleaf and CanniMed, among others [4] - Aurora is also a major player in the agricultural sector with a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants [4] Market Presence - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB," indicating its established presence in the financial markets [5]

Core Insights - Aurora Cannabis Inc. is participating as a leader in the inaugural Global Cannabis Regulatory Summit (GCRS) in Washington, D.C. on March 26-27, 2025, highlighting its role in advocating for policy reform in the cannabis industry [1][2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3] - The company offers a diverse portfolio of adult-use brands including Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard, as well as medical cannabis brands such as MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. [3] - Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3] Industry Engagement - The GCRS will facilitate discussions among regulators, members of Congress, international policy experts, and cannabis industry executives to shape the future of the global cannabis industry [2][3] - Aurora's participation in panel discussions aims to enhance understanding of the distinctions between medical and adult-use cannabis, informed by international political and regulatory consensus [3]